CEACAM5 and colorectal cancer: It appears possible, however, that an immunohistochemical tumor tissue analysis documenting high-level CEA expression in a non-colorectal cancer could identify individual patients for whom CEA serum levels would also be suited for monitoring response to therapy and early detection of tumor relapse.